423 related articles for article (PubMed ID: 2525826)
1. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of synthetic atrial natriuretic factor on blood pressure and sodium excretion in spontaneously hypertensive rats.
Kohzuki M; Abe K; Yasujima M; Kasai Y; Kanazawa M; Sato M; Hiwatari M; Omata K; Kudo K; Takeuchi K
Tohoku J Exp Med; 1989 Mar; 157(3):279-88. PubMed ID: 2524909
[TBL] [Abstract][Full Text] [Related]
3. Diuretic and natriuretic responses to ANF in the presence and absence of renal nerves in DOCA-salt hypertensive rats.
Patel KP; Zeigler DW
Clin Exp Hypertens; 1993 Mar; 15(2):257-70. PubMed ID: 8467316
[TBL] [Abstract][Full Text] [Related]
4. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
6. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic and hypotensive effects of alpha-human atrial natriuretic polypeptide in anaesthetized DOCA-salt hypertensive rats.
Kondo K; Kida O; Kangawa K; Matsuo H; Tanaka K
Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):97-101. PubMed ID: 2940041
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats.
Garcia R; Thibault G; Gutkowska J; Cantin M
Clin Exp Hypertens A; 1986; 8(7):1127-47. PubMed ID: 2945679
[TBL] [Abstract][Full Text] [Related]
9. The diuretic chlorthalidone normalizes baroreceptor and Bezold-Jarisch reflexes in DOCA-salt hypertensive rats.
Bissoli NS; Cicilini MA; Vasquez EC; Cabral AM
Pharmacol Res; 2000 Apr; 41(4):483-91. PubMed ID: 10704274
[TBL] [Abstract][Full Text] [Related]
10. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
[TBL] [Abstract][Full Text] [Related]
11. Chronic effect of a synthetic atrial natriuretic factor on the development of hypertension in young spontaneously hypertensive rats.
Kohzuki M; Abe K; Yasujima M; Tanno M; Kasai Y; Sato M; Omata K; Kudo K; Takeuchi K; Yoshinaga K
J Hypertens Suppl; 1986 Oct; 4(3):S487-9. PubMed ID: 2946833
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor.
Watkins RW; Vemulapalli S; Chiu PJ; Foster C; Smith EM; Neustadt B; Haslanger M; Sybertz EJ
Am J Hypertens; 1993 May; 6(5 Pt 1):357-68. PubMed ID: 8512660
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor content of brain nuclei in deoxycorticosterone acetate-salt hypertension in the rat.
Geiger H; Bahner U; Palkovits M; Hupe J; Heidland A
Clin Sci (Lond); 1989 Nov; 77(5):529-34. PubMed ID: 2531054
[TBL] [Abstract][Full Text] [Related]
14. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat.
Wilson SK; Lynch DR; Ladenson PW
Endocrinology; 1989 Jun; 124(6):2799-808. PubMed ID: 2542000
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific regulation of renal and cardiac atrial natriuretic factor gene expression in deoxycorticosterone acetate-salt rats.
Ogawa T; Bruneau BG; Yokota N; de Bold ML; de Bold AJ
Hypertension; 1997 Dec; 30(6):1342-7. PubMed ID: 9403551
[TBL] [Abstract][Full Text] [Related]
17. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.
Schiffrin EL; St-Louis J
Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791
[TBL] [Abstract][Full Text] [Related]
18. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.
Vemulapalli S; Chiu PJ; Brown A; Griscti K; Sybertz EJ
Life Sci; 1991; 49(5):383-91. PubMed ID: 1649942
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of atrial natriuretic factor to renal glomeruli in Doca- and Doca-salt-treated rats correlation with atrial and plasma levels.
Gauquelin G; Schiffrin EL; Cantin M; Garcia R
Biochem Biophys Res Commun; 1987 May; 145(1):522-31. PubMed ID: 3036134
[TBL] [Abstract][Full Text] [Related]
20. Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertension.
Sugimoto T; Ishii M; Hirata Y; Matsuoka H; Sugimoto T; Miyata A; Toshimori T; Masuda H; Kangawa K; Matsuo H
Life Sci; 1986 Apr; 38(15):1351-8. PubMed ID: 2937987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
